Clinical Trial Update: THR-18's Pharmacokinetics and Pharmacodynamics in Subjects With Acute Ischemic Stroke Treated With tPA [Phase 2]

View source ↗

Summary

Phase 2 study evaluating THR-18's pharmacokinetics and pharmacodynamics in patients with acute ischemic stroke treated with tissue plasminogen activator (tPA); …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Alteplase (alteplase)
• THR-18

Snippet

Sponsor: D-Pharm Ltd. | Conditions: Stroke, Acute | Phase 2 | Status: COMPLETED